Prenylisoflavonoids from<i>Erythrina senegalensis</i>as Novel HIV-1 Protease Inhibitors

Record type:

paper

Creator:

JiSWonJonYon

Publisher:

Geo

Host:

Visit

Similar

Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled TrialKinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C proteaseDesigning a Prognostics Framework for Pharmaceutical Development: Applying PHM Principles to Computational Drug Discovery for Novel HIV-1 C(SA) Protease Inhibitors<i>In Silico</i> Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase InhibitorsNovel inhibitors designing against the potential drug target of <i>Plasmodium falciparum</i> M17 Leucyl Aminopeptidase – PfM17LAPComputational investigation of <i>Arbutus serratifolia</i> Salisb molecules as new potential SARS-CoV-2 inhibitors

Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial

Background: Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are recommended as

Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease

Herein, we report the effect of nine FDA approved protease inhibitor drugs against a new HIV-1 su

Designing a Prognostics Framework for Pharmaceutical Development: Applying PHM Principles to Computational Drug Discovery for Novel HIV-1 C(SA) Protease Inhibitors

Prognostics and Health Management (PHM) has transformed the engineering industry through accurate pr

<i>In Silico</i> Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase Inhibitors

Human African Trypanosomiasis is endemic to 37 countries of sub-Saharan Africa. It is caused by two

Novel inhibitors designing against the potential drug target of <i>Plasmodium falciparum</i> M17 Leucyl Aminopeptidase – PfM17LAP

Abstract Malaria is one of the major disease of concern worldwi

Computational investigation of <i>Arbutus serratifolia</i> Salisb molecules as new potential SARS-CoV-2 inhibitors

Abstract The outbreak of the current pandemic and the evolution of virus resistance